Natascha Röhlen

8PUBLICATIONS

83CO-AUTHORS

Cancer cell biologyTumour immunologyInnate immunityMedical infection agents (incl. prions)Predictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jun 03, 2026

Claudin-1 targeting suppresses tumor growth, invasion, and metastasis in patient-derived cholangiocarcinoma models.

|Apr 21, 2026

CD48<sup>+</sup> tumour-associated macrophages: novel immunotherapeutic targets in hepatocellular carcinoma.

|Feb 06, 2026

Single-cell profiling reveals diverse γδ T cell subsets in ulcerative colitis.

Lena S Mayer, Jakob Arnold, Felix Roettele

|Jan 26, 2026

Hepatocellular Carcinoma - from Immunobiology to Immunotherapy.

Charlotte Rennert, Michael Schultheiß, Robert Thimme

|Feb 24, 2025

MCAM is a prognostic biomarker in patients with liver cirrhosis and HCC.

Eva Stockinger, Hendrik Luxenburger, Dominik Bettinger

|Sep 27, 2023

Prediction of postembolization syndrome after transarterial chemoembolization of hepatocellular carcinoma and its impact on prognosis.

Natascha Roehlen, Fabian Stoehr, Lukas Müller

Pageof 2

Frequent Collaborators

Robert Thimme

Maike Hofmann

Markus Meyer

Zeina Nehme

Fabio Del Zompo

Frank Jühling

Joachim Lupberger

Mathias Heikenwälder

Laura Meiss-Heydmann

Yujin Hoshida

Frequent Collaborators

Robert Thimme

Maike Hofmann

Markus Meyer

Zeina Nehme